ABSTRACT

ALTHOUGH GONORRHEA had been recognized clinically since antiquity, the etiological agent was not identified until 1879. By 1906, the gonococcus had been successfully cultured and differentially stained. With the advent of sulfonamides and penicillin, easy treatment became available for the cure of diagnosed cases. It soon became apparent, however, that the control of this disease would not be possible with therapeutic programs alone. During 1961, 265,665 cases of gonorrhea were reported in the US.1 It was felt, however, that the reported number was about one tenth the actual incidence or more than 2,000,000 cases a year. Throughout the world, cases of gonorrhea have shown a steady increase, especially in teen-age groups.

In almost every report, males outnumber females 3:1 in seeking medical attention for gonorrhea. With syphilis, however, statistics indicate that the prevalence is approximately the same in both sexes. Since both diseases are acquired in like manner, this

First Page Preview

Figures

Tables

References

Letters

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with
the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.

Return to: Urethritis in Males Produced by Neisseria Gonorrhoeae From Asymptomatic Females

This feature is provided as a courtesy. By using it you agree that that you are requesting the material solely for personal, non-commercial use, and that it is subject to the AMA's Terms of Use. The information provided in order to email this article will not be shared, sold, traded, exchanged, or rented. Please refer to The JAMA Network's Privacy Policy for additional information.

Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.